These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11361702)

  • 1. Doxil receives FDA market clearance.
    AIDS Patient Care STDS; 1996 Apr; 10(2):135. PubMed ID: 11361702
    [No Abstract]   [Full Text] [Related]  

  • 2. DOXIL approved by FDA.
    AIDS Patient Care; 1995 Dec; 9(6):306. PubMed ID: 11361446
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA approves KS drug. Food and Drug Administration. Florida Department of Health and Rehabilitation Services.
    AIDS Alert; 1996 Jan; 11(1):11-2. PubMed ID: 11363227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KS treatment inches forward.
    Vazquez E
    Posit Aware; 1996; 7(5):9. PubMed ID: 11363790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal doxorubicin (Doxil).
    Porche DJ
    J Assoc Nurses AIDS Care; 1996; 7(2):55-9. PubMed ID: 8679968
    [No Abstract]   [Full Text] [Related]  

  • 6. New treatment for KS offers options for therapy.
    AIDS Alert; 1996 Feb; 11(2):21-2. PubMed ID: 11363236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal doxorubicin: new preparation. Useful in Kaposi's sarcoma.
    Prescrire Int; 1998 Jun; 7(35):69-70. PubMed ID: 10342919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel for treating KS.
    Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxil offers hope to KS sufferers.
    Prescott LM
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):43-4. PubMed ID: 11363097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal chemotherapies.
    Smart T
    GMHC Treat Issues; 1995; 9(7/8):13. PubMed ID: 11362653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma: DaunoXome approved.
    AIDS Treat News; 1996 May; (no 246):3-4. PubMed ID: 11363485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOXIL superior for KS.
    Posit Aware; 1995; ():7. PubMed ID: 11362576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomal KS drugs approved.
    GMHC Treat Issues; 1996 Apr; 10(4):8-9. PubMed ID: 11363710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOXIL approved for KS.
    James JS
    AIDS Treat News; 1995 Dec; (no 236):6. PubMed ID: 11363051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal daunorubicin marketed for HIV-related Kaposi's sarcoma.
    Am J Health Syst Pharm; 1996 Jul; 53(13):1500, 1505. PubMed ID: 8809269
    [No Abstract]   [Full Text] [Related]  

  • 16. DaunoXome offers KS treatment alternative.
    AIDS Alert; 1996 Jun; 11(6):67-8. PubMed ID: 11363544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin in sterically stabilized liposomes.
    Lasic DD
    Nature; 1996 Apr; 380(6574):561-2. PubMed ID: 8606781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin liposome formulation gains marketing approval.
    Am J Health Syst Pharm; 1996 Jan; 53(2):116, 119. PubMed ID: 8653476
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50-1. PubMed ID: 11363534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxil®--the first FDA-approved nano-drug: lessons learned.
    Barenholz Y
    J Control Release; 2012 Jun; 160(2):117-34. PubMed ID: 22484195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.